This is a preview of subscription content, log in via an institution to check access.
Reference
EMA. Review of Tysabri started. Internet Document : 8 May 2015. Available from: URL: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Tysabri_20/Procedure_started/WC500186685.pdf
Rights and permissions
About this article
Cite this article
Natalizumab-associated risk of PML: EMA review underway. Reactions Weekly 1552, 7 (2015). https://doi.org/10.1007/s40278-015-0803-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-0803-7